1 / 8

Healthcare Group

U.S. Anti-Allergic Therapies Markets Prescription To Over-the-Counter Switches Put Prescription Products Under Intense Price Pressure. “Patent expirations of leading prescription drugs will result in the introduction of new generic and OTC products that compete with

iona-clements
Télécharger la présentation

Healthcare Group

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Anti-Allergic Therapies MarketsPrescription To Over-the-Counter Switches Put Prescription Products Under Intense Price Pressure “Patent expirations of leading prescription drugs will result in the introduction of new generic and OTC products that compete with incumbent brands, increasing patient usage but significantly pressuring prices.” Healthcare Group

  2. Industry Trends • Key patent expirations lead to new generic and OTC products • Insurers continue to drop coverage of more expensive drugs • Low-cost private label Loratadine pressures prescription products • The pipeline of new prescription products continues to shrink • Consumers continue to be confused by different allergy drugs

  3. Key Features • Frost & Sullivan Provides: • Detailed insights into recent developments and trends • Drivers, restraints, challenges, and strategic recommendations • Analyst insights on ‘hot topics’ and emerging applications in the U.S. anti-allergic therapies market • Market sizing and competitive analysis • Market forecasts and opportunity analysis • Quarterly assessments • End-user analysis within each report

  4. What We Offer • Coverage: The United States • Proven methodology encompassing extensive primary and secondary data and research • Focused information and strategies that cover business and technology • issues • Credible data and analysis highlighting industry dynamics • Winning strategies to help you create precise business plans

  5. Who Will Benefit? Current Market Participants • Find out how you compare to the competition • Assess current and future drivers and restraints • Determine and exploit new market share opportunities New Entrants • Analyze challenges associated with the industry • Calculate time scales for strategy implementation • Position yourself to capitalize on the market’s unmet needs Investment Community • Analyze long-term strategies of anti-allergies therapy companies • Determine which participants will outperform the competition • Assess attractiveness of investing in the anti-allergies therapies market

  6. What’s Included • Prescription antihistamines • Prescription corticosteroids • Over-the-counter allergy products

  7. Key Market Participants • AEN Corp. • Alcon Laboratories • AstraZeneca • Aventis • Collegium Pharmaceuticals • GlaxoSmithKline • Ivax Pharmaceuticals • Johnson & Johnson • Leiner Health Products • MedPointe Pharmaceuticals • Pfizer • Pharmacia Diagnostics AB • Schering-Plough Corp. • Wellpoint Health Networks, Inc. • Wyeth .

  8. For More Information • Call toll free 877 GO FROST (877.463.7876) • Fax toll free 888.690.3329 • E-mail myfrost@frost.com • Visit www.frost.com

More Related